A high throughput drug screen for Entamoeba histolytica identifies a new lead and target

[1]  M. Gramiccia,et al.  A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition , 2011, Amino Acids.

[2]  M. Suematsu,et al.  Two Atypical l-Cysteine-regulated NADPH-dependent Oxidoreductases Involved in Redox Maintenance, l-Cystine and Iron Reduction, and Metronidazole Activation in the Enteric Protozoan Entamoeba histolytica* , 2010, The Journal of Biological Chemistry.

[3]  P. Dorrestein,et al.  A Novel Entamoeba histolytica Cysteine Proteinase, EhCP4, Is Key for Invasive Amebiasis and a Therapeutic Target* , 2010, The Journal of Biological Chemistry.

[4]  A. Miele,et al.  Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin , 2009, The Journal of Biological Chemistry.

[5]  R. Nelson,et al.  Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia , 2008, British Journal of Pharmacology.

[6]  Anna V. Protasio,et al.  Platyhelminth Mitochondrial and Cytosolic Redox Homeostasis Is Controlled by a Single Thioredoxin Glutathione Reductase and Dependent on Selenium and Glutathione* , 2008, Journal of Biological Chemistry.

[7]  Anton Simeonov,et al.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis , 2008, Nature Medicine.

[8]  A. Casini,et al.  New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications , 2008, FEBS letters.

[9]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[10]  A. Holmgren,et al.  Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide , 2007, Proceedings of the National Academy of Sciences.

[11]  E. Davioud‐Charvet,et al.  Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target , 2007, PLoS medicine.

[12]  C. Craik,et al.  Use of Recombinant Entamoeba histolytica Cysteine Proteinase 1 To Identify a Potent Inhibitor of Amebic Invasion in a Human Colonic Model , 2007, Eukaryotic Cell.

[13]  A. Iglesias,et al.  Thioredoxin-linked metabolism in Entamoeba histolytica. , 2007, Free radical biology & medicine.

[14]  P. Das,et al.  The 29-Kilodalton Thiol-Dependent Peroxidase of Entamoeba histolytica Is a Factor Involved in Pathogenesis and Survival of the Parasite during Oxidative Stress , 2007, Eukaryotic Cell.

[15]  V. Gladyshev,et al.  Selenium metabolism in Trypanosoma: characterization of selenoproteomes and identification of a Kinetoplastida-specific selenoprotein , 2006, Nucleic acids research.

[16]  Shailendra Singh,et al.  Synthesis, spectral studies and in vitro assessment for antiamoebic activity of new cyclooctadiene ruthenium(II) complexes with 5-nitrothiophene-2-carboxaldehyde thiosemicarbazones. , 2005, Bioorganic & medicinal chemistry letters.

[17]  R. Heald,et al.  A Rae1-Containing Ribonucleoprotein Complex Is Required for Mitotic Spindle Assembly , 2005, Cell.

[18]  M. Landry,et al.  Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death. , 2004, Experimental cell research.

[19]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[20]  E. Jacquet,et al.  Characterization of Saccharomyces cerevisiae Ras1p and chimaeric constructs of Ras proteins reveals the hypervariable region and farnesylation as critical elements in the adenylyl cyclase signaling pathway. , 2003, Biochemistry.

[21]  D. Townsend,et al.  The importance of glutathione in human disease. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[22]  C. Moskaluk,et al.  The Mouse Model of Amebic Colitis Reveals Mouse Strain Susceptibility to Infection and Exacerbation of Disease by CD4+ T Cells1 , 2002, The Journal of Immunology.

[23]  S. Müller,et al.  The diversity and evolution of thioredoxin reductase: new perspectives. , 2002, Trends in parasitology.

[24]  S. Rahlfs,et al.  The thioredoxin system of Plasmodium falciparum and other parasites , 2002, Cellular and Molecular Life Sciences CMLS.

[25]  T. Takeuchi,et al.  Effect of calcium antagonists, calcium channel blockers and calmodulin inhibitors on the growth and encystation of Entamoeba histolytica and E. invadens , 2001, Parasitology Research.

[26]  W. Wernsdorfer,et al.  Effects of Miltefosine and Other Alkylphosphocholines on Human Intestinal ParasiteEntamoeba histolytica , 2001, Antimicrobial Agents and Chemotherapy.

[27]  T. Takeuchi,et al.  Inhibition of encystation of Entamoeba invadens by wortmannin , 2001, Parasitology Research.

[28]  R. Schirmer,et al.  Thioredoxin reductase two modes of catalysis have evolved. , 2000, European journal of biochemistry.

[29]  M. Ludwig,et al.  Twists in catalysis: alternating conformations of Escherichia coli thioredoxin reductase. , 2000, Science.

[30]  E. Tannich,et al.  Metronidazole Resistance in the Protozoan Parasite Entamoeba histolytica Is Associated with Increased Expression of Iron-containing Superoxide Dismutase and Peroxiredoxin and Decreased Expression of Ferredoxin 1 and Flavin Reductase* , 1999, The Journal of Biological Chemistry.

[31]  Jones Js,et al.  Life in the 21st century - a vision for all. , 1998 .

[32]  David M Brown,et al.  Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. , 1997, The Journal of antimicrobial chemotherapy.

[33]  K. Lamp,et al.  Metronidazole. A therapeutic review and update. , 1997, Drugs.

[34]  S. Mulrooney.  Application of a single-plasmid vector for mutagenesis and high-level expression of thioredoxin reductase and its use to examine flavin cofactor incorporation. , 1997, Protein expression and purification.

[35]  G. Newton,et al.  Entamoeba histolytica: a eukaryote without glutathione metabolism. , 1984, Science.

[36]  Y. Cheng,et al.  Purine metabolism in primitive erythrocytes. , 1973, Comparative biochemistry and physiology. B, Comparative biochemistry.

[37]  S. Stanley,et al.  Transcriptomic comparison of two Entamoeba histolytica strains with defined virulence phenotypes identifies new virulence factor candidates and key differences in the expression patterns of cysteine proteases, lectin light chains, and calmodulin. , 2007, Molecular and biochemical parasitology.

[38]  A. Holmgren,et al.  Thioredoxin and related molecules--from biology to health and disease. , 2007, Antioxidants & redox signaling.

[39]  E. Oldfield,et al.  Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo. , 2004, Journal of medicinal chemistry.

[40]  G. D. Pearson,et al.  Protein electrophoretic mobility shift assay to monitor redox state of thioredoxin in cells. , 2002, Methods in enzymology.

[41]  D. Ron,et al.  Arsenite-inducible RNA-associated protein (AIRAP) protects cells from arsenite toxicity , 2001, Cell stress & chaperones.

[42]  J. Jones,et al.  Life in the 21st century - a vision for all. , 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[43]  J. Ravdin,et al.  Amebiasis: human infection with Entamoeba histolytica. , 1994, Progress in clinical parasitology.

[44]  J. Hook,et al.  Carcinogenicity study of auranofin, an orally administered gold compound, in mice. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[45]  D. Krogstad,et al.  Problems with current therapeutic regimens. , 1988 .

[46]  Gottlieb Nl.  Pharmacology of auranofin: overview and update. , 1986, Scandinavian journal of rheumatology. Supplement.

[47]  L S Diamond,et al.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.